Research output per year
Research output per year
Personal profile
Biography
A/Prof Hawkes (MBBS Hons, FRACP, DMedSc) is the Lymphoma Lead at the Olivia Newton-John Cancer Centre, Austin Health and Eastern Health in Melbourne Australia. After completing Medical Oncology training in Melbourne, she undertook a fellowship at the Royal Marsden Hospital, UK and doctoral studies at Melbourne University. She is founder and past president of the Australasian Lymphoma Alliance, chairs the Australasian Leukaemia and Lymphoma Trials Group Lymphoma Working Party, and is a member of Steering Committees for Australian National Lymphoma Registry and international Women in Lymphoma group. A/Prof Hawkes runs a large research program focusing on immune targets in lymphoma and has over 70 publications. She is an active member of ASCO, ASH and EHA as well as the International TCL Consortium.
Education/Academic qualification
Lymphoma, DMedSci, University of Melbourne
… → Jan 2017
Bachelor of Medicine/Bachelor of Surgery, MBBS (Hons), MONASH UNIVERSITY
1996 → 2001
External positions
Medical Oncologist, Lymphoma Lead, Austin Health
Oct 2013 → …Medical Oncologist, Lymphoma Lead, Eastern Health
2013 → …Research area keywords
- Lymphoma
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic
Loh, Z., Hawkes, E. A., Chionh, F., Azad, A. & Chong, G., Feb 2021, In : Clinical Lymphoma, Myeloma and Leukemia. 21, 2, p. e179-e184 6 p.Research output: Contribution to journal › Article › Research › peer-review
-
A consensus statement on the use of biosimilar medicines in hematology in Australia
Gregory, G. P., Carrington, C., Cheah, C. Y., Hawkes, E. A., Irving, I. M., Siderov, J. & Opat, S., Aug 2020, In : Asia-Pacific Journal of Clinical Oncology. 16, 4, p. 211-221 16 p.Research output: Contribution to journal › Review Article › Other › peer-review
Open Access1 Citation (Scopus) -
Caution in expanding the use of abbreviated R-CHOP to poor-risk limited-stage DLBCL
Hawkes, E. A., Opat, S. & Hertzberg, M., 10 Dec 2020, In : Journal of Clinical Oncology. 38, 35, p. 4221-4222 2 p.Research output: Contribution to journal › Letter › Other › peer-review
1 Citation (Scopus) -
Pembrolizumab in relapsed or refractory Richter syndrome
Armand, P., Murawski, N., Molin, D., Zain, J., Eichhorst, B., Gulbas, Z., Hawkes, E. A., Pagel, J. M., Phillips, T., Ribrag, V., Svoboda, J., Stathis, A., Chatterjee, A., Orlowski, R., Marinello, P. & Christian, B., 1 Jul 2020, In : British Journal of Haematology. 190, 2, p. e117-e120 4 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access1 Citation (Scopus) -
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma
Ng, Z. Y., Bishton, M., Ritchie, D., Campbell, R., Gilbertson, M., Hill, K., Ratnasingam, S., Schwarer, A., Manos, K., Shorten, S., Ng, M., Nelson, N., Xin, L., De Mel Widanalage, S., Sunny, T., Purtill, D., Poon, M., Johnston, A., Cochrane, T., Lee, H. P. & 6 others, , Aug 2019, In : Hematological Oncology. 37, 3, p. 253-260 8 p.Research output: Contribution to journal › Article › Research › peer-review